AVEO Pharmaceuticals Inc

NASDAQ:AVEO   3:59:53 PM EDT
6.76
+0.09 (+1.35%)
Debt Financing / Related, Other Pre-Announcement

Aveo Pharmaceuticals Inc Says CANbridge Life Sciences Ltd Exercised Its Right To Terminate Agreement With Co Pertaining To AV-203

Published: 03/15/2021 20:55 GMT
AVEO Pharmaceuticals Inc (AVEO) - Aveo Pharmaceuticals Inc - on March 9, 2021, Canbridge Life Sciences Ltd.
Exercised Its Right to Terminate Agreement With Co Pertaining to Av-203.
Aveo Pharmaceuticals Inc - Termination is Effective As of September 5, 2021.
Aveo Pharmaceuticals Inc - Pursuant to Terms of Agreement, Company Expects Transfer of Av-203 Program to Be Complete by Effective Date.
Aveo Pharmaceuticals Inc - Company Expects to Regain Rights to Av-203 Program Outside of North America by Effective Date.